Prognostic factors in patients with pancreatic ductal adenocarcinoma with neoadjuvant treatment and pancreatectomy

被引：0
|
作者：
Kawada, Tomoyuki [1 ]
机构：
[1] Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo, Japan
来源：
JOURNAL OF SURGICAL ONCOLOGY | 2022年 / 125卷 / 06期
关键词：
D O I：
10.1002/jso.26819
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1071 / 1071
页数：1
相关论文
共 50 条
  • [41] Pancreatic ductal adenocarcinoma: time for a neoadjuvant revolution?
    Roberto Salvia
    Giuseppe Malleo
    Laura Maggino
    Michele Milella
    Claudio Bassi
    Updates in Surgery, 2020, 72 : 321 - 324
  • [42] Neoadjuvant therapy for localized pancreatic ductal adenocarcinoma
    Brown, Zachary J.
    Shannon, Alexander H.
    Cloyd, Jordan M.
    MINERVA SURGERY, 2024, : 315 - 325
  • [43] Adjuvant and neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma
    Leonhardt Carl S.
    Traub Benno
    Hackert Thilo
    Klaiber Ulla
    Strobel Oliver
    Büchler Markus W.
    Neoptolemos John P.
    Department of General
    Department of Surgery
    胰腺病学杂志（英文）, 2020, 03 (01) : 1 - 11
  • [44] Pancreatic ductal adenocarcinoma: time for a neoadjuvant revolution?
    Salvia, Roberto
    Malleo, Giuseppe
    Maggino, Laura
    Milella, Michele
    Bassi, Claudio
    UPDATES IN SURGERY, 2020, 72 (02) : 321 - 324
  • [45] Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma
    Tinchon, Christoph
    Hubmann, Eva
    Pichler, Angelika
    Keil, Felix
    Pichler, Martin
    Rabl, Hans
    Uggowitzer, Martin
    Jilek, Kurt
    Leitner, Gerhard
    Bauernhofer, Thomas
    ACTA ONCOLOGICA, 2013, 52 (06) : 1231 - 1234
  • [46] Prognostic significance of mean corpuscular volume in patients with pancreatic ductal adenocarcinoma and multimodal treatment
    Jomrich, Gerd
    Gruber, Maximilian
    Gruber, Elisabeth S.
    Muehlbacher, Jakob
    Radosavljevic, Sanja
    Wilfing, Lavinia
    Winkler, Daniel
    Prager, Gerald
    Reiterer, Christian
    Kabon, Barbara
    Haslacher, Helmuth
    Sahora, Klaus
    Schindl, Martin
    JOURNAL OF VISCERAL SURGERY, 2024, 161 (02) : 99 - 105
  • [47] Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy
    Shohei Takaichi
    Yoshito Tomimaru
    Shogo Kobayashi
    Keisuke Toya
    Kazuki Sasaki
    Yoshifumi Iwagami
    Daisaku Yamada
    Takehiro Noda
    Hidenori Takahashi
    Tadafumi Asaoka
    Masahiro Tanemura
    Yuichiro Doki
    Hidetoshi Eguchi
    Annals of Surgical Oncology, 2023, 30 : 2458 - 2468
  • [48] Prognostic value of adjacent organ resection in patients with left-sided pancreatic ductal adenocarcinoma following distal pancreatectomy
    Song, Ki Byung
    Kwon, Jaewoo
    Kim, Yong Woon
    Hwang, Dae Wook
    Lee, Jae Hoon
    Hong, Sarang
    Lee, Jong Woo
    Hwang, Kyungyeon
    Yoo, Daegwang
    Kim, Song Cheol
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2019, 26 (06) : 227 - 234
  • [49] Prognostic impact of nodal statuses in patients with pancreatic ductal adenocarcinoma
    Fukuda, Yasunari
    Asaoka, Tadafumi
    Maeda, Sakae
    Hama, Naoki
    Miyamoto, Atsushi
    Mori, Masaki
    Doki, Yuichiro
    Nakamori, Shoji
    PANCREATOLOGY, 2017, 17 (02) : 279 - 284
  • [50] Prognostic Significance of Cofilin Isoforms in Patients With Pancreatic Ductal Adenocarcinoma
    Islam, Shajedul
    Kitagawa, Takao
    Kuramitsu, Yasuhiro
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
12345